Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report) ...
Shares of ResMed Inc. RMD advanced 1.44% to $239.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and ...
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should ...
People who have trouble breathing as they sleep often turn to ResMed, which makes a face-worn breathing apparatus. Its ...
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...
We profile four US stocks that burst past their year-high to determine if they should be in your growth stocks portfolio. The ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...
Analysts are bullish on these names. Let's find out why they rate them as buys. The post Where to invest $10,000 into ASX 200 ...
William Blair lowered their Q3 2025 EPS estimates for ResMed in a research report issued on Monday, February 3rd. William Blair analyst M. Andrew now anticipates that the medical equipment provider ...
Shares of ResMed Inc. RMD shed 2.23% to $237.18 Thursday, on what proved to be an all-around mixed trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results